cancer

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic…

1 year ago

Blind to the burn: Misconceptions about skin cancer risk in the US

Skin cancer is the most common cancer in the United States and a significant health issue, with millions of non-melanoma…

1 year ago

Targeted alpha therapy: Breakthrough in treating refractory skin cancer

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of…

1 year ago

Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumour growth by increasing cancer stemness in an…

1 year ago

Researchers find improved method for treating rare, aggressive, pregnancy-related cancer

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new…

1 year ago

New research unlocks key to long-lasting immune response in cancer and chronic diseases

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline…

1 year ago

Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and…

1 year ago

Putting a lid on excess cholesterol to halt bladder cancer cell growth

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could…

1 year ago

Surprising ‘two-faced’ cancer gene role supports paradigm shift in predicting disease

A genetic fault long believed to drive the development of oesophageal cancer may in fact play a protective role early…

1 year ago

Scientists unveil surprising human vs mouse differences in a major cancer immunotherapy target

Since its discovery in the 1990s, "programmed cell death protein 1," or PD-1, has been regarded as a leading target…

1 year ago